WEBVTT - How Eli Lilly Got Huge by Making Us Thin

0:00:01.040 --> 0:00:05.720
<v Speaker 1>How Eli Lilly got huge by making us thin. Dave

0:00:05.800 --> 0:00:07.960
<v Speaker 1>Rix steered the one hundred and fifty year old drug

0:00:08.000 --> 0:00:11.360
<v Speaker 1>giant to a one trillion dollar market cap. Can he

0:00:11.440 --> 0:00:15.320
<v Speaker 1>defeat Pharmer's Boom and Bust cycle? By Madison, Muller and

0:00:15.360 --> 0:00:21.080
<v Speaker 1>brad Stone Read aloud by Mark Leedorf. When Dave Rix

0:00:21.120 --> 0:00:24.560
<v Speaker 1>became chief executive officer of Eli Lilly in twenty seventeen,

0:00:24.960 --> 0:00:28.960
<v Speaker 1>he was facing an industry under siege. Americans held drug

0:00:29.000 --> 0:00:32.280
<v Speaker 1>companies in lower esteem than airlines, law firms, and even

0:00:32.320 --> 0:00:36.840
<v Speaker 1>the federal government. President Donald Trump, then starting his first term,

0:00:37.240 --> 0:00:40.760
<v Speaker 1>was excoriating them for their high prices. A mounting number

0:00:40.760 --> 0:00:43.760
<v Speaker 1>of reports showed that soaring costs were even forcing some

0:00:43.880 --> 0:00:44.960
<v Speaker 1>diabetics to ration.

0:00:45.120 --> 0:00:48.080
<v Speaker 2>Insulin. Rix, the eleventh.

0:00:47.680 --> 0:00:51.080
<v Speaker 1>CEO in Lily's one hundred and fifty year history, concedes

0:00:51.200 --> 0:00:55.480
<v Speaker 1>that one was a public relations nightmare. Eventually it became personal.

0:00:55.880 --> 0:00:58.160
<v Speaker 1>One day, he received a letter from a young boy

0:00:58.360 --> 0:01:00.640
<v Speaker 1>detailing the links to which his mother was going to

0:01:00.680 --> 0:01:05.160
<v Speaker 1>a Ford insulin. Similar messages piled in from others. Rix

0:01:05.240 --> 0:01:07.800
<v Speaker 1>says he read almost all of them, and about ninety

0:01:07.840 --> 0:01:11.760
<v Speaker 1>percent accused Lily of price gouging patients. I couldn't sit

0:01:11.800 --> 0:01:15.119
<v Speaker 1>there and accept it. He recalls, it was a major problem.

0:01:15.560 --> 0:01:19.240
<v Speaker 1>Almost a decade later, the mood that Lily has shifted dramatically.

0:01:19.760 --> 0:01:24.240
<v Speaker 1>The company's hit diabetes shot Mountjaro and obesity shot Zepbound

0:01:24.560 --> 0:01:28.640
<v Speaker 1>have transformed its fortunes and in many ways, its public image.

0:01:28.720 --> 0:01:32.080
<v Speaker 1>Lily is the most valuable healthcare corporation in the world,

0:01:32.319 --> 0:01:35.360
<v Speaker 1>joining only a dozen or so other companies, mostly in tech,

0:01:35.680 --> 0:01:39.679
<v Speaker 1>that have reached a one trillion dollar market capitalization. Rix,

0:01:39.920 --> 0:01:43.840
<v Speaker 1>formerly just another embattled pharmaceutical executive in Washington, is a

0:01:43.880 --> 0:01:47.199
<v Speaker 1>frequent White House ally who helped persuade the Trump administration

0:01:47.360 --> 0:01:51.360
<v Speaker 1>to expand Medicare coverage for obesity drugs. Even the mail

0:01:51.480 --> 0:01:55.280
<v Speaker 1>is better these days. Patients send him rapturous testimonials of

0:01:55.280 --> 0:01:58.120
<v Speaker 1>their weight loss success, complete with before.

0:01:57.840 --> 0:01:58.840
<v Speaker 2>And after photos.

0:01:59.800 --> 0:02:02.720
<v Speaker 1>Two year old correspondent told Rix that his daughter said

0:02:02.760 --> 0:02:06.760
<v Speaker 1>he'd almost certainly die before sixty. Then he started Mountjaro

0:02:06.920 --> 0:02:10.359
<v Speaker 1>and shed more than two hundred pounds in eighteen months.

0:02:10.480 --> 0:02:12.640
<v Speaker 1>His only wish was to go to his daughter's wedding,

0:02:12.800 --> 0:02:15.680
<v Speaker 1>Rix says, and he was like, now I can do it.

0:02:16.760 --> 0:02:20.240
<v Speaker 1>Millions of patients all over the world are taking Manjaro, zepbound,

0:02:20.480 --> 0:02:23.840
<v Speaker 1>and other glp ie receptor agonists made by Lilly and

0:02:23.880 --> 0:02:29.240
<v Speaker 1>its long time rival, Denmark based Novo Nordisk. These revolutionary drugs,

0:02:29.600 --> 0:02:32.880
<v Speaker 1>the acronym stands for a glucagon like peptide on a

0:02:32.960 --> 0:02:36.080
<v Speaker 1>gut hormone the medicines are designed to mimic, have surged

0:02:36.120 --> 0:02:39.359
<v Speaker 1>in popularity thanks to their ability to suppress people's appetites

0:02:39.639 --> 0:02:44.160
<v Speaker 1>and melt away stubborn pounds. Available first as injections and

0:02:44.200 --> 0:02:47.920
<v Speaker 1>then also as oral medications, glp ones are beginning to

0:02:47.960 --> 0:02:51.920
<v Speaker 1>turn the tide on the US obesity epidemic, an unfathomable

0:02:51.960 --> 0:02:55.400
<v Speaker 1>outcome a few years ago. Now, their efficacy is being

0:02:55.400 --> 0:02:59.240
<v Speaker 1>studied for other potentially deadly conditions, including heart disease and

0:02:59.280 --> 0:03:04.040
<v Speaker 1>drug addiction, with promising results. Investors can't get enough of

0:03:04.080 --> 0:03:07.919
<v Speaker 1>Lily's drugs. Since Mountjaro was approved in May twenty twenty two,

0:03:08.280 --> 0:03:11.440
<v Speaker 1>It has passed mrk's cancer blockbuster key Truda as the

0:03:11.440 --> 0:03:15.440
<v Speaker 1>world's best selling medication, helping bump Lily's stock nearly three

0:03:15.560 --> 0:03:20.200
<v Speaker 1>hundred percent. Zetbound is the planet's most popular obesity medicine,

0:03:20.240 --> 0:03:21.679
<v Speaker 1>despite being released only.

0:03:21.480 --> 0:03:22.320
<v Speaker 2>Two years ago.

0:03:22.880 --> 0:03:26.560
<v Speaker 1>Rix says Lily is shipping seven Zetbound injections every second.

0:03:27.280 --> 0:03:30.600
<v Speaker 1>Found Dio, a daily pill introduced in April that also

0:03:30.639 --> 0:03:33.680
<v Speaker 1>helps patients lose weight, has already racked up about eighty

0:03:33.760 --> 0:03:37.600
<v Speaker 1>nine thousand prescriptions, according to analysts, even though the company

0:03:37.640 --> 0:03:39.560
<v Speaker 1>only recently started advertising it.

0:03:40.240 --> 0:03:41.240
<v Speaker 2>People are also.

0:03:41.160 --> 0:03:44.280
<v Speaker 1>Clamoring to get their hands on reta truetide, a next

0:03:44.360 --> 0:03:48.640
<v Speaker 1>generation compound Lily has in testing. That drug, which mimics

0:03:48.640 --> 0:03:51.920
<v Speaker 1>three different hormones versus two for Zepbound and one for

0:03:52.000 --> 0:03:55.720
<v Speaker 1>Novo's Wegovi, yielded average weight loss of twenty eight percent

0:03:55.840 --> 0:03:59.240
<v Speaker 1>across eighteen months in a late stage trial, a decline

0:03:59.280 --> 0:04:03.720
<v Speaker 1>previously thought possible only through gastric bypass surgery, and Lily

0:04:03.800 --> 0:04:05.480
<v Speaker 1>has more obesity drugs coming.

0:04:06.080 --> 0:04:07.080
<v Speaker 2>We basically put a.

0:04:07.120 --> 0:04:10.320
<v Speaker 1>Bet on every rational idea and said we should be

0:04:10.360 --> 0:04:14.840
<v Speaker 1>first or best on every conceivable concept. Rick says, Behind

0:04:14.840 --> 0:04:18.640
<v Speaker 1>the Blockbusters is a company that's been remade by Rix's personality,

0:04:19.000 --> 0:04:22.359
<v Speaker 1>with speed the top priority and mistakes not an option.

0:04:23.000 --> 0:04:28.119
<v Speaker 1>He's resolved widespread supply shortages, supercharged research and development, poured

0:04:28.160 --> 0:04:32.400
<v Speaker 1>billions of dollars into manufacturing and artificial intelligence, and pioneered

0:04:32.520 --> 0:04:37.159
<v Speaker 1>direct to consumer strategies, including launching Lily Direct, an online

0:04:37.200 --> 0:04:40.760
<v Speaker 1>platform where patients can connect with doctors and get obesity drugs.

0:04:41.480 --> 0:04:44.960
<v Speaker 1>These moves have helped Lily capitalize on the obesity boom

0:04:45.000 --> 0:04:48.559
<v Speaker 1>in ways its peers have struggled to match Novo, whose

0:04:48.560 --> 0:04:52.360
<v Speaker 1>diabetes drug Ozepic created the modern weight loss Frenzy has

0:04:52.400 --> 0:04:57.720
<v Speaker 1>stumbled amid US pricing pressures, lagging insurance coverage, intensifying competition,

0:04:57.839 --> 0:05:01.880
<v Speaker 1>and especially by assuming its early life would hold. Lily

0:05:02.000 --> 0:05:04.520
<v Speaker 1>is just playing at a completely different game level than

0:05:04.600 --> 0:05:08.680
<v Speaker 1>any other pharmaceutical company, says Wiley Shao, who spent eighteen

0:05:08.760 --> 0:05:11.279
<v Speaker 1>years at Lily and is now president of virtual care

0:05:11.320 --> 0:05:15.520
<v Speaker 1>platform provider Omada Health. The test for Rix now is

0:05:15.600 --> 0:05:19.440
<v Speaker 1>whether Lily can outlast the industry's familiar boom and bust cycle.

0:05:19.960 --> 0:05:23.320
<v Speaker 1>Although drug patents last about two decades, they are typically

0:05:23.400 --> 0:05:27.200
<v Speaker 1>granted years in advance of US Food and Drug Administration approval,

0:05:27.520 --> 0:05:29.640
<v Speaker 1>so companies don't get that much time to reap a

0:05:29.680 --> 0:05:34.159
<v Speaker 1>profit before cheaper generics begin to erode sales. Roughly half

0:05:34.200 --> 0:05:37.600
<v Speaker 1>of Lily's revenue last year came from Manjaro and zepbound,

0:05:37.760 --> 0:05:41.600
<v Speaker 1>a precarious dependency for any drug company. While Lily has

0:05:41.640 --> 0:05:44.479
<v Speaker 1>about a decade of patent protection left on those drugs.

0:05:44.800 --> 0:05:49.040
<v Speaker 1>The competition is already intensifying. Hundreds of thousands of people

0:05:49.040 --> 0:05:52.200
<v Speaker 1>are taking Novo's new wigov pill, and at least one

0:05:52.279 --> 0:05:55.560
<v Speaker 1>hundred and twenty companies, a third of them in China collectively,

0:05:55.560 --> 0:05:59.400
<v Speaker 1>have hundreds of such drugs in development, according to Bloomberg Intelligence.

0:06:00.080 --> 0:06:02.640
<v Speaker 1>The rapid rise of AI has also introduced a new

0:06:02.640 --> 0:06:06.160
<v Speaker 1>threat that the next big drug will come from Silicon Valley,

0:06:06.560 --> 0:06:10.239
<v Speaker 1>and Lily has some internal challenges too, with insiders saying

0:06:10.279 --> 0:06:13.320
<v Speaker 1>it's newly hard driving corporate culture has led to high

0:06:13.360 --> 0:06:15.320
<v Speaker 1>executive turnover and poor morale.

0:06:16.400 --> 0:06:17.600
<v Speaker 2>Rix is undeterred.

0:06:18.080 --> 0:06:20.720
<v Speaker 1>Now in his tenth year as CEO, he says he

0:06:20.760 --> 0:06:23.880
<v Speaker 1>wants to imbue Eli Lilly with the consistency and dominance

0:06:23.920 --> 0:06:27.480
<v Speaker 1>of technology giants such as Apple and Amazon. In addition

0:06:27.520 --> 0:06:30.359
<v Speaker 1>to flooding Lily's pipeline with new treatments, He's got the

0:06:30.360 --> 0:06:34.200
<v Speaker 1>company on an unprecedented acquisition spree and in a ubiquitous

0:06:34.240 --> 0:06:38.040
<v Speaker 1>advertising campaign that seeks to inspire Nike like brand fidelity.

0:06:38.839 --> 0:06:41.480
<v Speaker 1>If you look at healthcare, most people would say it is,

0:06:41.880 --> 0:06:45.760
<v Speaker 1>perhaps next to government services, the worst consumer experience they

0:06:45.800 --> 0:06:49.360
<v Speaker 1>have every day, Rick says, But he adds there are

0:06:49.400 --> 0:06:51.960
<v Speaker 1>a bunch of people posting on Reddit. When their package

0:06:52.040 --> 0:06:54.800
<v Speaker 1>arrives from Lily at their door, they unwrap it, they

0:06:54.839 --> 0:06:56.040
<v Speaker 1>make a video of it.

0:06:56.040 --> 0:06:58.520
<v Speaker 2>It's like an iPhone. It's an exciting moment.

0:06:59.680 --> 0:07:03.039
<v Speaker 1>In eighteen seventy six, a former Union Army colonel named

0:07:03.080 --> 0:07:07.479
<v Speaker 1>Eli Lilly opened a small laboratory on Pearl Street in Indianapolis.

0:07:07.960 --> 0:07:10.960
<v Speaker 1>He wanted to improve on the eras patent medicines and

0:07:11.080 --> 0:07:15.240
<v Speaker 1>counter snake oil salesmen by making quality products patients could trust.

0:07:15.840 --> 0:07:19.760
<v Speaker 1>It took some time. Early medications such as succus alteran

0:07:20.080 --> 0:07:23.360
<v Speaker 1>marketed as a blood purifier for syphilis, and other ailments,

0:07:23.600 --> 0:07:27.480
<v Speaker 1>were themselves little more than quackery, but Lily eventually found

0:07:27.520 --> 0:07:31.560
<v Speaker 1>success selling pills coated in gelatine, a major improvement on

0:07:31.600 --> 0:07:35.559
<v Speaker 1>the putrid medicinal liquids and powders patients commonly choked down.

0:07:36.320 --> 0:07:39.200
<v Speaker 1>Over the following one hundred and fifty years, Lily grew

0:07:39.280 --> 0:07:42.360
<v Speaker 1>from that tiny two story brick building into a powerhouse

0:07:42.400 --> 0:07:46.560
<v Speaker 1>with roughly fifty thousand employees around the world today. Its

0:07:46.600 --> 0:07:50.720
<v Speaker 1>Indianapolis headquarters, a mile north of the original operation, is

0:07:50.760 --> 0:07:54.000
<v Speaker 1>so large it has its own zip code. In that time,

0:07:54.080 --> 0:07:56.960
<v Speaker 1>it's been at the forefront of addressing America's most pressing

0:07:57.000 --> 0:08:03.280
<v Speaker 1>ailments and anxieties diabetes, polio, depression, erectile dysfunction, COVID nineteen,

0:08:03.760 --> 0:08:07.880
<v Speaker 1>and now obesity. In the early two thousands, Lily learned

0:08:07.880 --> 0:08:09.600
<v Speaker 1>what it was like to have the profits from an

0:08:09.680 --> 0:08:14.800
<v Speaker 1>enormously popular drug, vanish virtually overnight Prozac, approved as a

0:08:14.840 --> 0:08:17.960
<v Speaker 1>breakthrough treatment for depression in nineteen eighty seven, by then

0:08:18.040 --> 0:08:21.280
<v Speaker 1>accounted for about a quarter of the company's sales, prescribed

0:08:21.280 --> 0:08:24.680
<v Speaker 1>to tens of millions of patients. Executives tried to plan

0:08:24.760 --> 0:08:26.760
<v Speaker 1>for the loss of crucial patents for the drug in

0:08:26.800 --> 0:08:30.520
<v Speaker 1>two thousand and one, focusing heavily on mental health, cancer,

0:08:30.600 --> 0:08:34.400
<v Speaker 1>and diabetes. But although Lily's research led to the development

0:08:34.440 --> 0:08:37.680
<v Speaker 1>of glp ie drugs for diabetes, the company failed to

0:08:37.679 --> 0:08:40.200
<v Speaker 1>find a replacement hit at the time, and in the

0:08:40.240 --> 0:08:43.760
<v Speaker 1>process it ignored some early research showing how GLP one's

0:08:43.880 --> 0:08:47.600
<v Speaker 1>might help with obesity. By two thousand and eight, Lily

0:08:47.640 --> 0:08:49.760
<v Speaker 1>had lost a third of its revenue since the turn

0:08:49.800 --> 0:08:52.160
<v Speaker 1>of the century and had seen an even bigger drop

0:08:52.200 --> 0:08:55.400
<v Speaker 1>in profits. It was forced to undertake a massive cost

0:08:55.400 --> 0:08:59.160
<v Speaker 1>cutting effort that eliminated fifty five hundred jobs, roughly fourteen

0:08:59.200 --> 0:09:02.120
<v Speaker 1>percent of its workfe From two thousand and five to

0:09:02.120 --> 0:09:04.920
<v Speaker 1>two thousand and nine, the company got only two new

0:09:05.000 --> 0:09:08.640
<v Speaker 1>drugs approved, a blood thinner called Effiant and a diabetes

0:09:08.679 --> 0:09:13.120
<v Speaker 1>treatment called Bayeta. Novo Nordisk, in contrast, was moving on

0:09:13.200 --> 0:09:16.800
<v Speaker 1>GLP one's for weight loss by twenty thirteen, when the

0:09:16.800 --> 0:09:20.920
<v Speaker 1>American Medical Association declared obesity a chronic disease and not

0:09:21.040 --> 0:09:24.040
<v Speaker 1>the result of weak will power or bad lifestyle choices,

0:09:24.400 --> 0:09:28.240
<v Speaker 1>it was ready. The next year, Novo got approval for Saxinda,

0:09:28.640 --> 0:09:31.120
<v Speaker 1>the first GLP one drug cleared for weight.

0:09:30.960 --> 0:09:31.960
<v Speaker 2>Loss in the US.

0:09:32.800 --> 0:09:36.040
<v Speaker 1>Those were formative years for Rix, who joined Lily as

0:09:36.080 --> 0:09:39.439
<v Speaker 1>a business development associate in nineteen ninety six after growing

0:09:39.480 --> 0:09:42.439
<v Speaker 1>up in the San Francisco Bay area and studying industrial

0:09:42.480 --> 0:09:46.960
<v Speaker 1>management at Purdue University. He ascended the ranks managing Lily's

0:09:46.960 --> 0:09:50.040
<v Speaker 1>businesses in Canada and China before returning to oversee the

0:09:50.040 --> 0:09:53.800
<v Speaker 1>company's most important market. Along the way, he developed a

0:09:53.840 --> 0:09:57.560
<v Speaker 1>reputation as an uncompromising manager with an aversion to the

0:09:57.679 --> 0:10:02.080
<v Speaker 1>Lily nice culture of harmonious colors. Aberation shortly after Rix

0:10:02.200 --> 0:10:05.640
<v Speaker 1>joined the executive committee. He remembers he asked then CEO

0:10:05.800 --> 0:10:09.880
<v Speaker 1>John Lechlider for some constructive feedback. You have an over

0:10:09.920 --> 0:10:13.679
<v Speaker 1>developed sense of urgency, lack Lighter told him, you mean

0:10:13.720 --> 0:10:17.960
<v Speaker 1>I'm impatient. Rix replied, He's like, yeah, sometimes it gets

0:10:18.000 --> 0:10:22.360
<v Speaker 1>you in trouble. I'm like, okay, some trouble's good. In

0:10:22.440 --> 0:10:26.719
<v Speaker 1>July twenty sixteen, Lily announced Rix would become CEO. At

0:10:26.720 --> 0:10:29.120
<v Speaker 1>the time, it took an average of thirteen to fourteen

0:10:29.200 --> 0:10:31.720
<v Speaker 1>years for a promising medication to make it through the

0:10:31.720 --> 0:10:36.040
<v Speaker 1>company's test labs to an FDA approval decision. Dan Skovronsky,

0:10:36.280 --> 0:10:39.680
<v Speaker 1>Lily's chief scientific and product officer, says he remembers the

0:10:39.679 --> 0:10:43.320
<v Speaker 1>speech Rix gave when he started as CEO, especially the

0:10:43.360 --> 0:10:46.720
<v Speaker 1>priority on speed. It's not just about getting to the

0:10:46.760 --> 0:10:49.280
<v Speaker 1>patients faster. Of course, we care a lot about that

0:10:49.800 --> 0:10:53.719
<v Speaker 1>or beating your competitors, Skovronsky says, summing up the message,

0:10:54.040 --> 0:10:56.640
<v Speaker 1>it's also such a tough business that you need to learn,

0:10:56.679 --> 0:11:00.000
<v Speaker 1>and you can learn faster if you move faster. That year,

0:11:00.280 --> 0:11:03.920
<v Speaker 1>Novo published impressive results from a weekly GLP one shot

0:11:04.000 --> 0:11:07.720
<v Speaker 1>that went on to become ozimpic under Rix, Lily needed

0:11:07.760 --> 0:11:10.680
<v Speaker 1>to come up with something better. He turned to Skovronsky,

0:11:10.840 --> 0:11:14.520
<v Speaker 1>a physician, neuroscientist, and entrepreneur who joined the company after

0:11:14.559 --> 0:11:18.120
<v Speaker 1>it acquired his startup, Avid Radio Pharmaceuticals in twenty ten.

0:11:18.960 --> 0:11:22.960
<v Speaker 1>Lily scientists had been experimenting with combinations of GLP one's

0:11:23.000 --> 0:11:25.840
<v Speaker 1>and other gut hormones, which had the potential to be

0:11:25.880 --> 0:11:29.640
<v Speaker 1>more powerful than GLP one's alone. That research led to

0:11:29.720 --> 0:11:33.080
<v Speaker 1>early stage testing of several different compounds, one of which

0:11:33.120 --> 0:11:37.319
<v Speaker 1>stood out to Skovronsky ter zeppetide. In just a month,

0:11:37.480 --> 0:11:40.520
<v Speaker 1>healthy volunteers who took the drug lost from three percent

0:11:40.559 --> 0:11:43.520
<v Speaker 1>to five percent of their body weight. We said, this

0:11:43.720 --> 0:11:46.439
<v Speaker 1>is working, he recalls, this is really going to be

0:11:46.480 --> 0:11:50.840
<v Speaker 1>a special medicine. At Rix's direction, Skovronsky was also working

0:11:50.880 --> 0:11:54.199
<v Speaker 1>on an initiative to cut Lily's development timeline in half.

0:11:54.800 --> 0:11:57.640
<v Speaker 1>We tried to reinvent every step of the drug development

0:11:57.720 --> 0:12:02.400
<v Speaker 1>process with an eye on Speedsky says. Terzepetide was the

0:12:02.480 --> 0:12:05.960
<v Speaker 1>first molecule that got the full speed treatment. He turned

0:12:06.000 --> 0:12:08.800
<v Speaker 1>the R and D department into a pseudo biotech startup,

0:12:09.120 --> 0:12:12.120
<v Speaker 1>calling the group gip Bio in reference to one of

0:12:12.120 --> 0:12:15.239
<v Speaker 1>the hormones, the drug mimics, and freeing it from bureaucratic

0:12:15.280 --> 0:12:19.480
<v Speaker 1>requirements such as commercial viability assessments. We were hungry to

0:12:19.520 --> 0:12:22.160
<v Speaker 1>prove ourselves, Skovronsky said at an R and d D

0:12:22.160 --> 0:12:27.319
<v Speaker 1>eight years later. Terzepetide won FDA approval in twenty twenty two,

0:12:27.480 --> 0:12:31.080
<v Speaker 1>roughly five years after Rix and Skovronsky decided to expedite it.

0:12:31.600 --> 0:12:34.320
<v Speaker 1>Lily had been so optimistic about the drug, which would

0:12:34.360 --> 0:12:37.199
<v Speaker 1>be branded as mount Jaro, that it had started looking

0:12:37.200 --> 0:12:40.719
<v Speaker 1>at manufacturing sites nearly four years before the approval came

0:12:40.760 --> 0:12:44.120
<v Speaker 1>through a step it had never taken before. Rix was

0:12:44.160 --> 0:12:47.240
<v Speaker 1>determined to catch up to Novo. We're not going to

0:12:47.280 --> 0:12:51.360
<v Speaker 1>lose because someone leapfrogged us, he remembers thinking. By the

0:12:51.400 --> 0:12:54.280
<v Speaker 1>time zep bound was approved in late twenty twenty three,

0:12:54.640 --> 0:12:58.079
<v Speaker 1>GLP one hype was at a fever pitch. Patients were

0:12:58.120 --> 0:13:01.360
<v Speaker 1>documenting their weight loss journeys on tik talk and swapping

0:13:01.400 --> 0:13:04.720
<v Speaker 1>tips for managing side effects on Reddit, but Novo was

0:13:04.720 --> 0:13:08.760
<v Speaker 1>struggling to manufacture enough semiglutide, the active ingredient in nozepic,

0:13:08.800 --> 0:13:12.920
<v Speaker 1>and Wigovy. Seeking an edge, Lily priced zetbound about twenty

0:13:12.960 --> 0:13:17.320
<v Speaker 1>percent cheaper than wegovy. It also introduced Lily Direct, whose

0:13:17.400 --> 0:13:21.439
<v Speaker 1>launch had been closely managed by Rix himself. There, patients

0:13:21.440 --> 0:13:23.840
<v Speaker 1>could connect online with doctors to get a weight loss

0:13:23.880 --> 0:13:27.640
<v Speaker 1>drug prescription and pay directly if their insurance didn't cover it, as.

0:13:27.679 --> 0:13:28.480
<v Speaker 2>Was often the case.

0:13:29.280 --> 0:13:32.080
<v Speaker 1>The site was janky at first, but today fifty five

0:13:32.120 --> 0:13:35.360
<v Speaker 1>percent of new zetbound patients are buying through Lily Direct.

0:13:36.240 --> 0:13:39.559
<v Speaker 1>Demand quickly spiraled out of control for Lily, however, as

0:13:39.600 --> 0:13:43.040
<v Speaker 1>it had for Novo. Within months, patients across the US

0:13:43.080 --> 0:13:47.280
<v Speaker 1>were clamoring to find zetbound in stock at local pharmacies. Frantic,

0:13:47.520 --> 0:13:51.679
<v Speaker 1>some railed against both companies on social media. Many turned

0:13:51.720 --> 0:13:55.199
<v Speaker 1>to telehealth providers such as Roe and Hymns and hers Health,

0:13:55.600 --> 0:13:58.760
<v Speaker 1>which were selling cheaper, copycat versions of the drugs, something

0:13:58.760 --> 0:14:02.280
<v Speaker 1>that's allowed when medicines are in short supply. Rix pushed

0:14:02.280 --> 0:14:05.520
<v Speaker 1>his staff to get the situation under control, pouring billions

0:14:05.559 --> 0:14:10.280
<v Speaker 1>into Lily's manufacturing sites in Indiana, North Carolina, Wisconsin, Ireland,

0:14:10.280 --> 0:14:13.880
<v Speaker 1>and Germany. Our workers come every hour of every day

0:14:13.920 --> 0:14:16.400
<v Speaker 1>to every plant in the world to make more twenty

0:14:16.440 --> 0:14:20.440
<v Speaker 1>four to seven three sixty five overtime weekends holidays. Rix

0:14:20.440 --> 0:14:24.160
<v Speaker 1>told Bloomberg BusinessWeek in twenty twenty four. We're operating above

0:14:24.200 --> 0:14:29.000
<v Speaker 1>the theoretical capacity of those sites. Lily's bottlenecks, unlike Novo's,

0:14:29.120 --> 0:14:32.320
<v Speaker 1>stemmed not from an ingredient shortage, but from the complexity

0:14:32.320 --> 0:14:35.480
<v Speaker 1>of its plastic injector pins. The company found a work

0:14:35.480 --> 0:14:38.400
<v Speaker 1>around by instead offering the drug in a small, single

0:14:38.520 --> 0:14:41.920
<v Speaker 1>use vial. This required customers to fill a syringe and

0:14:42.040 --> 0:14:45.720
<v Speaker 1>inject the drug themselves, but such was Zepbound's promise that

0:14:45.800 --> 0:14:50.840
<v Speaker 1>most overcame any squeamishness. Novo, lacking an immediate solution, was

0:14:50.840 --> 0:14:53.680
<v Speaker 1>forced to limit the sale of introductory with govy doses.

0:14:54.240 --> 0:14:56.400
<v Speaker 1>You cannot make it hard for your customers to get

0:14:56.440 --> 0:14:59.400
<v Speaker 1>your product, especially if there's an alternative that may even

0:14:59.400 --> 0:15:02.760
<v Speaker 1>be a little better better, says BMO Capital Markets analyst

0:15:02.800 --> 0:15:08.080
<v Speaker 1>Evan Seigerman. When you do, you permanently change behaviors. Vials

0:15:08.120 --> 0:15:11.560
<v Speaker 1>were also cheaper to produce than pens, so in August

0:15:11.560 --> 0:15:14.760
<v Speaker 1>twenty twenty four, Rix cut the price of zetbound vials

0:15:14.800 --> 0:15:17.640
<v Speaker 1>in half on Lily Direct, the only place that offered

0:15:17.680 --> 0:15:20.280
<v Speaker 1>them at the time. Patients could now buy the drug

0:15:20.320 --> 0:15:22.240
<v Speaker 1>there for as little as three hundred and ninety nine

0:15:22.280 --> 0:15:25.880
<v Speaker 1>dollars a month. Single use zetbound vials quickly became the

0:15:25.920 --> 0:15:29.480
<v Speaker 1>site's best selling product, allowing Lily to capitalize on the

0:15:29.480 --> 0:15:32.360
<v Speaker 1>burgeoning cash pay market in a way that Novo, which

0:15:32.480 --> 0:15:34.840
<v Speaker 1>wasn't selling we Go vi in vials and didn't have

0:15:34.880 --> 0:15:38.480
<v Speaker 1>a direct consumer site, couldn't. It took the Danish company

0:15:38.480 --> 0:15:41.200
<v Speaker 1>an additional seven months to roll out a similarly low

0:15:41.200 --> 0:15:43.800
<v Speaker 1>priced offering and more than a year to start its

0:15:43.840 --> 0:15:46.520
<v Speaker 1>own consumer website, but by then it.

0:15:46.520 --> 0:15:47.160
<v Speaker 2>Was too late.

0:15:47.520 --> 0:15:50.280
<v Speaker 1>With Rix at the helm, Lily had turned the tables,

0:15:50.480 --> 0:15:53.920
<v Speaker 1>surpassing its chief rival in the most economically and culturally

0:15:53.920 --> 0:15:58.480
<v Speaker 1>transformative drug category in recent memory. We'll be right back

0:15:58.520 --> 0:16:02.040
<v Speaker 1>with how Eli Lilly got huge by making us then.

0:16:05.120 --> 0:16:08.680
<v Speaker 1>Welcome back to how Eli Lilly got huge by making

0:16:08.760 --> 0:16:14.160
<v Speaker 1>us then. The opportunity before Lily was vast. Obesity effects

0:16:14.200 --> 0:16:16.800
<v Speaker 1>more than one hundred million people in the US and

0:16:16.880 --> 0:16:21.120
<v Speaker 1>one billion around the world. Many more are considered clinically overweight.

0:16:21.800 --> 0:16:24.680
<v Speaker 1>Countless business empires have been built around the age old

0:16:24.800 --> 0:16:29.240
<v Speaker 1>challenge of helping people shed unwonted pounds and GLP. Ones

0:16:29.360 --> 0:16:32.880
<v Speaker 1>weren't a fad diet or a willpower testing exercise. Regimen,

0:16:33.040 --> 0:16:37.040
<v Speaker 1>but rather a scientifically proven drug with few serious side effects.

0:16:37.520 --> 0:16:40.800
<v Speaker 1>Lily's focus shifted from making enough medicine to putting it

0:16:40.840 --> 0:16:43.800
<v Speaker 1>in the hands of as many patients as possible, including

0:16:43.840 --> 0:16:47.160
<v Speaker 1>those covered by Medicare, and to cultivating a deeper connection

0:16:47.360 --> 0:16:52.120
<v Speaker 1>with their customers. The brand overhaul started with Lena Polimeni, who,

0:16:52.240 --> 0:16:54.680
<v Speaker 1>during a twenty two year career at Lily, had gone

0:16:54.720 --> 0:16:58.360
<v Speaker 1>from peddling medicines to Los Angeles area doctors to serving

0:16:58.400 --> 0:17:01.960
<v Speaker 1>as the company's top marketing excitative. For the campaign she

0:17:02.080 --> 0:17:05.840
<v Speaker 1>was planning, Paulmenni wanted to hire Portland, Oregon based advertising

0:17:05.880 --> 0:17:09.480
<v Speaker 1>firm Widen and Kennedy, best known for its relationship with Nike.

0:17:10.119 --> 0:17:14.040
<v Speaker 1>But such was the poor reputation of drug advertising, characterized

0:17:14.080 --> 0:17:18.600
<v Speaker 1>by euphemistic references to illnesses, blithely smiling patients, and long

0:17:18.680 --> 0:17:23.280
<v Speaker 1>regulatory disclosures encompassing every conceivable side effect that the agency

0:17:23.400 --> 0:17:27.200
<v Speaker 1>rejected Lily I had to reverse pitch them three times.

0:17:27.240 --> 0:17:31.560
<v Speaker 1>Paulmenni says they didn't want to work in pharma. Eventually,

0:17:31.640 --> 0:17:34.480
<v Speaker 1>she persuaded Widen and Kennedy to give Lily a chance,

0:17:34.760 --> 0:17:37.480
<v Speaker 1>and together they produced a short film. During the pandemic

0:17:37.800 --> 0:17:41.359
<v Speaker 1>when the COVID vaccines were making Pfizer and Moderna household names.

0:17:41.960 --> 0:17:44.840
<v Speaker 1>The spot established a friendly new identity for Lily as

0:17:44.880 --> 0:17:49.600
<v Speaker 1>a medicine company. Some of Paulmeni's colleagues, including Rix, still

0:17:49.640 --> 0:17:52.400
<v Speaker 1>needed convincing of the merits of a larger campaign, though

0:17:52.920 --> 0:17:55.080
<v Speaker 1>there were a lot of discussions in terms of whether

0:17:55.119 --> 0:17:58.560
<v Speaker 1>this was the right thing to do. Polmeni recalls Rix

0:17:58.600 --> 0:18:01.880
<v Speaker 1>wanted to make sure the imagery is incorporated doctors and scientists,

0:18:02.240 --> 0:18:05.600
<v Speaker 1>but he eventually gave the green light. When a sponsor

0:18:05.640 --> 0:18:08.159
<v Speaker 1>of the US Olympic team backed out ahead of the

0:18:08.160 --> 0:18:12.399
<v Speaker 1>pandemic delayed Tokyo Summer Games in twenty twenty one, Paulameni

0:18:12.520 --> 0:18:15.639
<v Speaker 1>got her chance to go big. Lily stepped in to

0:18:15.640 --> 0:18:19.040
<v Speaker 1>promote not one of its drug franchises, but the company itself.

0:18:19.520 --> 0:18:23.560
<v Speaker 1>The move was successful enough that its brand advertising became ubiquitous,

0:18:23.720 --> 0:18:28.320
<v Speaker 1>appearing almost anywhere potential patients might be paying attention, the Oscars,

0:18:28.359 --> 0:18:31.520
<v Speaker 1>the super Bowl, the subway. We want people to know

0:18:31.560 --> 0:18:34.640
<v Speaker 1>that we're here for you, Rick says, envisioning a world

0:18:34.680 --> 0:18:38.760
<v Speaker 1>where customers gravitate toward trusted Lily drugs over competing options.

0:18:39.280 --> 0:18:43.480
<v Speaker 1>That's where we're headed. Brand awareness doesn't matter much, though,

0:18:43.680 --> 0:18:46.920
<v Speaker 1>if people can't afford the medicine, and most insurance companies

0:18:46.920 --> 0:18:49.959
<v Speaker 1>are still reluctant to cover GLP ones for weight loss.

0:18:50.520 --> 0:18:53.399
<v Speaker 1>Lily itself switched plans for the first time in ages

0:18:53.520 --> 0:18:57.879
<v Speaker 1>last year after its pharmacy benefit manager, CVS Caremark moved

0:18:57.960 --> 0:19:01.359
<v Speaker 1>zep bound off the plan's list of preferred mesas medications.

0:19:01.280 --> 0:19:03.040
<v Speaker 2>Caermark put it back on this may.

0:19:03.760 --> 0:19:06.840
<v Speaker 1>A not insignificant share of Lily's employees are on a

0:19:06.880 --> 0:19:10.520
<v Speaker 1>GLP one, Rick says, a fact underscored by the medical

0:19:10.560 --> 0:19:13.520
<v Speaker 1>waste containers full of used zep bound and Mount Jaro

0:19:13.640 --> 0:19:18.000
<v Speaker 1>pens in its campus bathrooms. Although obesity is a chronic disease,

0:19:18.359 --> 0:19:21.440
<v Speaker 1>half of the people don't have access or coverage forgetting treatment,

0:19:21.720 --> 0:19:25.360
<v Speaker 1>says Iliya Yufa, who oversees Lily's US business and has,

0:19:25.640 --> 0:19:28.679
<v Speaker 1>like Rix, been with the company for thirty years. The

0:19:28.760 --> 0:19:32.800
<v Speaker 1>access gap traditionally extended to Medicare, which until recently was

0:19:32.880 --> 0:19:36.280
<v Speaker 1>legally barred from covering drugs used solely for weight loss.

0:19:36.840 --> 0:19:40.520
<v Speaker 1>As for Medicaid, it's allowed, but expensive. The cost is

0:19:40.560 --> 0:19:44.160
<v Speaker 1>prohibitive enough that only thirteen US states currently cover weight

0:19:44.200 --> 0:19:47.760
<v Speaker 1>loss drugs, and some of the largest, including California, have

0:19:47.840 --> 0:19:51.359
<v Speaker 1>stopped doing so for that reason. During his most recent

0:19:51.440 --> 0:19:55.359
<v Speaker 1>presidential campaign, Trump promised to go after drug companies that

0:19:55.440 --> 0:19:58.320
<v Speaker 1>charge more for the same medications in America than in

0:19:58.359 --> 0:20:02.560
<v Speaker 1>other wealthy nations. After Trump won, Rix, who has personally

0:20:02.600 --> 0:20:06.679
<v Speaker 1>donated primarily two Republicans, started appearing on Fox News for

0:20:06.720 --> 0:20:10.040
<v Speaker 1>the first time in years and made frequent trips to Washington.

0:20:10.720 --> 0:20:13.919
<v Speaker 1>With the President also pushing American companies to invest in

0:20:13.960 --> 0:20:17.919
<v Speaker 1>domestic manufacturing, Lily announced it would spend twenty seven billion

0:20:18.000 --> 0:20:21.640
<v Speaker 1>dollars to build four new plants in the US. By spring,

0:20:21.920 --> 0:20:25.560
<v Speaker 1>Trump was almost obsessively touting Rix by name, referring to

0:20:25.640 --> 0:20:29.760
<v Speaker 1>him variously in speeches as a great gentleman, an incredible executive,

0:20:29.800 --> 0:20:32.920
<v Speaker 1>and one of the hottest people in the world. Trump

0:20:33.000 --> 0:20:35.359
<v Speaker 1>said Lily wouldn't be subject to the tariffs he was

0:20:35.359 --> 0:20:39.520
<v Speaker 1>threatening because it was investing in the US. Rix's relationships

0:20:39.520 --> 0:20:42.320
<v Speaker 1>in Washington served him well last summer, when the Trump

0:20:42.359 --> 0:20:45.399
<v Speaker 1>administration hauled drug makers into the White House for closed

0:20:45.440 --> 0:20:49.640
<v Speaker 1>door meetings about lowering drug prices. The negotiations carried on

0:20:49.720 --> 0:20:52.800
<v Speaker 1>into the fall, culminating in an infamous November event in

0:20:52.840 --> 0:20:56.280
<v Speaker 1>the Oval Office, at which Trump, Rix and Novo Nordisk

0:20:56.400 --> 0:20:59.800
<v Speaker 1>CEO Mike Doustar announced that Lily and Novo would cut

0:20:59.800 --> 0:21:02.800
<v Speaker 1>the prices of their weight loss medications in exchange for

0:21:02.840 --> 0:21:07.040
<v Speaker 1>Medicare reimbursement and a three year reprieve from tariffs. When

0:21:07.119 --> 0:21:09.959
<v Speaker 1>Rix got his moment to speak, a patient Lily had

0:21:09.960 --> 0:21:13.159
<v Speaker 1>brought to the event fainted in the background. Centers for

0:21:13.240 --> 0:21:16.520
<v Speaker 1>Medicare and Medicaid administrator memet Oz jumped in to help

0:21:16.560 --> 0:21:19.439
<v Speaker 1>the man, with Doustar and another executive holding up his

0:21:19.520 --> 0:21:22.720
<v Speaker 1>legs as Trump and Rix looked on. Footage of the

0:21:22.760 --> 0:21:26.280
<v Speaker 1>incident went viral, and Saturday Night Live spoofed it days later.

0:21:26.800 --> 0:21:31.119
<v Speaker 1>Cast member mikey Day played Rix, capturing his deliberate speaking style,

0:21:31.359 --> 0:21:35.040
<v Speaker 1>manicured Midwestern Polish, and utter astonishment at being caught in

0:21:35.080 --> 0:21:38.240
<v Speaker 1>the chaotic center of the political storm around drug prices

0:21:38.240 --> 0:21:42.840
<v Speaker 1>and GLP ones. For Rix, Who's fifty nine, the challenge

0:21:42.880 --> 0:21:45.880
<v Speaker 1>now is less about making history than about escaping it.

0:21:46.440 --> 0:21:49.320
<v Speaker 1>Every drug company lucky enough to have a wildly successful

0:21:49.359 --> 0:21:52.280
<v Speaker 1>medicine must reckon with the reality that sooner or later,

0:21:52.560 --> 0:21:56.879
<v Speaker 1>patents expire and competition arrives over a decade ago, to

0:21:56.920 --> 0:22:00.960
<v Speaker 1>take one example, expiring patents on astrozenic because Saraquell and

0:22:01.000 --> 0:22:04.600
<v Speaker 1>Crestor left the company in a dismal state, It struggled

0:22:04.640 --> 0:22:08.760
<v Speaker 1>for several years before CEO Pascal Sorio shifted his focus

0:22:08.760 --> 0:22:12.520
<v Speaker 1>to oncology and turned its fortunes around. There's a long

0:22:12.560 --> 0:22:15.840
<v Speaker 1>list of companies that did well, got big, and then failed.

0:22:15.960 --> 0:22:18.480
<v Speaker 1>Rick says, we don't want to be on that list.

0:22:19.240 --> 0:22:20.560
<v Speaker 2>As Lily tries.

0:22:20.280 --> 0:22:23.720
<v Speaker 1>To avoid a slump, the intensity has ratcheted up internally,

0:22:23.960 --> 0:22:27.320
<v Speaker 1>chipping away at the genial culture that long defined its workplace.

0:22:28.000 --> 0:22:31.919
<v Speaker 1>Rix has stringently maintained the company's headcount despite Lily's massive

0:22:31.920 --> 0:22:35.400
<v Speaker 1>growth in recent years, and four current and former employees

0:22:35.440 --> 0:22:39.359
<v Speaker 1>who requested anonymity to freely discussed internal matters say some

0:22:39.520 --> 0:22:43.399
<v Speaker 1>staff feel overworked and burned out. There's widespread fear that

0:22:43.480 --> 0:22:47.000
<v Speaker 1>making mistakes will lead to serious repercussions, and there's been

0:22:47.040 --> 0:22:50.160
<v Speaker 1>some loss of civility. Rix is known to be an

0:22:50.160 --> 0:22:54.200
<v Speaker 1>epic micromanager. One of the employees says, prone to getting

0:22:54.240 --> 0:22:58.240
<v Speaker 1>involved in projects CEOs normally wouldn't bother with, Meetings with

0:22:58.320 --> 0:23:01.480
<v Speaker 1>him can be intense. Several people will say, albeit because

0:23:01.520 --> 0:23:05.280
<v Speaker 1>he knows everyone's job better than they do. Rix bristles

0:23:05.320 --> 0:23:08.280
<v Speaker 1>at the suggestion that he's a micromanager, though he concedes

0:23:08.560 --> 0:23:11.080
<v Speaker 1>no problem is too small for his attention. If it's

0:23:11.119 --> 0:23:14.200
<v Speaker 1>important to the business, It's not about sticking your nose

0:23:14.240 --> 0:23:16.920
<v Speaker 1>in stuff and throwing your weight around, he says, it's

0:23:16.920 --> 0:23:20.119
<v Speaker 1>about proving to people that we can solve problems. At

0:23:20.119 --> 0:23:22.800
<v Speaker 1>a leadership off site, sometime in the past few years,

0:23:23.000 --> 0:23:26.359
<v Speaker 1>according to one of the former employees, he warned executives

0:23:26.440 --> 0:23:29.000
<v Speaker 1>Lily isn't an easy place to be and ask them

0:23:29.040 --> 0:23:31.600
<v Speaker 1>to honestly assess whether they were aligned with where the

0:23:31.640 --> 0:23:34.639
<v Speaker 1>company was heading. I think I'm easy to be with

0:23:34.800 --> 0:23:37.520
<v Speaker 1>and hard to work for. Rick says, that's in my

0:23:37.600 --> 0:23:41.439
<v Speaker 1>best days. I mean, we all have bad days. He adds,

0:23:41.840 --> 0:23:44.080
<v Speaker 1>I kind of hope Lily is like that, where we're

0:23:44.119 --> 0:23:47.159
<v Speaker 1>demanding as hell on the what, but really quite sympathetic

0:23:47.200 --> 0:23:47.680
<v Speaker 1>on the how.

0:23:48.600 --> 0:23:50.360
<v Speaker 2>As Lily works to sharpen.

0:23:50.040 --> 0:23:54.000
<v Speaker 1>Its edge, new products, aggressive rebates and mounting political pressure

0:23:54.119 --> 0:23:57.560
<v Speaker 1>have driven down GLP one prices far faster than many

0:23:57.560 --> 0:24:03.119
<v Speaker 1>investors expected, raising questions about future profitability. Generic versions of

0:24:03.160 --> 0:24:06.800
<v Speaker 1>Novo's GLP one drugs are already available in countries including

0:24:06.800 --> 0:24:10.560
<v Speaker 1>India and Canada. An industry giant such as abvi, Amgen,

0:24:10.640 --> 0:24:13.320
<v Speaker 1>and Pfizer are trying to develop obesity drugs that are

0:24:13.320 --> 0:24:16.879
<v Speaker 1>more tolerable, easier to take, or longer lasting than the

0:24:16.920 --> 0:24:21.280
<v Speaker 1>current options. Still, no one is leapfrogging Lily, at least

0:24:21.280 --> 0:24:24.240
<v Speaker 1>not yet. If anything, the company seems set to build

0:24:24.280 --> 0:24:27.920
<v Speaker 1>on its lead with plans to launch several new obesity medicines,

0:24:28.160 --> 0:24:30.400
<v Speaker 1>including drugs that may have fewer side effects.

0:24:30.840 --> 0:24:32.000
<v Speaker 2>Its next big thing.

0:24:31.920 --> 0:24:35.440
<v Speaker 1>Will likely be retatrutide, the three hormone drug that cut

0:24:35.440 --> 0:24:38.160
<v Speaker 1>weight by twenty eight percent in trials, which is due

0:24:38.160 --> 0:24:42.320
<v Speaker 1>out next year assuming it's approved. Although Lily originally positioned

0:24:42.320 --> 0:24:44.320
<v Speaker 1>it as something for people on the higher end of

0:24:44.320 --> 0:24:48.000
<v Speaker 1>the body mass index spectrum, Rix now sees mass market

0:24:48.000 --> 0:24:52.520
<v Speaker 1>potential at lower doses. There's already some evidence of that potential,

0:24:52.680 --> 0:24:55.600
<v Speaker 1>if not the kind Rix likes to see. People all

0:24:55.640 --> 0:24:58.800
<v Speaker 1>over the world have begun buying peptides, short chains of

0:24:58.800 --> 0:25:01.639
<v Speaker 1>amino acids that form the basis of GLP ones and

0:25:01.680 --> 0:25:06.360
<v Speaker 1>other medicines on the black market online shady overseas sellers

0:25:06.440 --> 0:25:09.480
<v Speaker 1>who've obtained the formula for Retta truetide from Lily's patent

0:25:09.520 --> 0:25:13.480
<v Speaker 1>applications and scientific papers are illegally hawking the drug under

0:25:13.560 --> 0:25:17.879
<v Speaker 1>names including REHTTA, GLP three, triple G, and even Rata

0:25:17.920 --> 0:25:21.359
<v Speaker 1>two E. This is before Lily has completed clinical testing

0:25:21.480 --> 0:25:24.439
<v Speaker 1>or safety reviews on the drug, and despite warnings from

0:25:24.480 --> 0:25:28.440
<v Speaker 1>the FDA that such sales are illegal. People say peptides

0:25:28.520 --> 0:25:32.520
<v Speaker 1>like a magic word. Rick says, but it's like saying chemical.

0:25:32.880 --> 0:25:35.439
<v Speaker 1>You wouldn't put a crop protection chemical in your body.

0:25:35.680 --> 0:25:38.359
<v Speaker 1>You wouldn't put just any peptide in your body, but

0:25:38.520 --> 0:25:41.919
<v Speaker 1>people somehow think it's magic beans. I think these products

0:25:41.920 --> 0:25:44.480
<v Speaker 1>should go through testing, they should be manufactured in a

0:25:44.520 --> 0:25:47.080
<v Speaker 1>control setting, and none of these things are occurring.

0:25:47.400 --> 0:25:48.760
<v Speaker 2>That's scary.

0:25:48.880 --> 0:25:52.440
<v Speaker 1>The industry is also worrying about potential usurpers from outside

0:25:52.440 --> 0:25:56.920
<v Speaker 1>the field. Anthropic, Google, OpenAI, and other companies are developing

0:25:57.000 --> 0:26:00.000
<v Speaker 1>artificial intelligence systems that could one day be capable of

0:26:00.200 --> 0:26:04.120
<v Speaker 1>designing novel molecules, raising the specter that the next generation

0:26:04.200 --> 0:26:07.639
<v Speaker 1>of breakthrough medicines won't be developed by a pharmaceutical company

0:26:07.680 --> 0:26:11.880
<v Speaker 1>at all. Rix has doubts. Naturally, there's no magic where

0:26:11.920 --> 0:26:14.359
<v Speaker 1>you can turn on a computer and invent a drug. Today,

0:26:14.680 --> 0:26:18.440
<v Speaker 1>he says, maybe we'll get there someday. He points out

0:26:18.440 --> 0:26:20.960
<v Speaker 1>the rich irony that Lily is taking over a South

0:26:21.000 --> 0:26:25.720
<v Speaker 1>San Francisco building previously occupied by Verily Alphabet's embattled life

0:26:25.720 --> 0:26:29.560
<v Speaker 1>Sciences unit, and adds it turns out that language models

0:26:29.560 --> 0:26:33.359
<v Speaker 1>are not good models for predictions of biology if AI

0:26:33.640 --> 0:26:36.520
<v Speaker 1>is going to reshape the industry, though Rix wants Lilly

0:26:36.560 --> 0:26:39.280
<v Speaker 1>to be a major participant. He's become a student of

0:26:39.320 --> 0:26:42.520
<v Speaker 1>the technology after toying with chat GPT over Christmas in

0:26:42.560 --> 0:26:46.080
<v Speaker 1>twenty twenty two and later taking a coding class alongside

0:26:46.080 --> 0:26:50.280
<v Speaker 1>his Chief Information and Digital officer dog Raw. I can

0:26:50.320 --> 0:26:53.520
<v Speaker 1>probably count on my fingers how many CEOs could actually

0:26:53.600 --> 0:26:56.240
<v Speaker 1>code or write a code for a large language model,

0:26:56.440 --> 0:27:01.040
<v Speaker 1>including tech CEOs RAO, says Rix, who calls himself a

0:27:01.080 --> 0:27:04.600
<v Speaker 1>tech nerd, admits to running two llms at once during

0:27:04.640 --> 0:27:08.200
<v Speaker 1>most meetings, in part to keep up with his brightest scientists.

0:27:08.720 --> 0:27:11.880
<v Speaker 1>These days, he favors Claude and Grock over chat GPT

0:27:12.760 --> 0:27:16.520
<v Speaker 1>signs all over Lily's Indianapolis headquarters encourage employees to use

0:27:16.560 --> 0:27:19.680
<v Speaker 1>the technology too. How will you change the game by

0:27:19.680 --> 0:27:24.680
<v Speaker 1>harnessing the power of AI? A cafeteria poster reads already.

0:27:24.760 --> 0:27:27.520
<v Speaker 1>Rick says, lily scientists have used it in ways that

0:27:27.560 --> 0:27:31.000
<v Speaker 1>are as impressive as Alpha fold, referring to Google's landmark

0:27:31.080 --> 0:27:35.920
<v Speaker 1>tool for predicting protein structures. Lily's AI drug discovery tools,

0:27:36.000 --> 0:27:38.879
<v Speaker 1>which have been trained on decades of in house research data,

0:27:39.119 --> 0:27:42.360
<v Speaker 1>are stored in tune Lab, a service that smaller biotech

0:27:42.400 --> 0:27:45.320
<v Speaker 1>companies can also access. All they have to do is

0:27:45.400 --> 0:27:48.920
<v Speaker 1>prove their real biotechs and not some Chinese AI lab

0:27:48.960 --> 0:27:53.240
<v Speaker 1>that's just like interrogating our models, Rick says. In twenty

0:27:53.280 --> 0:27:57.000
<v Speaker 1>twenty six, Lily unveiled a supercomputer built in partnership with

0:27:57.119 --> 0:28:00.520
<v Speaker 1>Nvidia that's designed to help researchers sift through vast amounts

0:28:00.520 --> 0:28:03.960
<v Speaker 1>of biological data and accelerate the search for new medicines.

0:28:04.440 --> 0:28:06.960
<v Speaker 1>The two companies are also building a one billion dollar

0:28:07.080 --> 0:28:09.960
<v Speaker 1>lab in San Francisco that will allow Lilly to advance

0:28:10.000 --> 0:28:14.320
<v Speaker 1>drug development and Nvidia to improve its FARMA capabilities. Beyond that,

0:28:14.520 --> 0:28:17.639
<v Speaker 1>Rick says, we have a data advantage because most of

0:28:17.680 --> 0:28:20.480
<v Speaker 1>the tech biocompanies that you talk to, even some of

0:28:20.480 --> 0:28:23.800
<v Speaker 1>the scale players, they're just training on public data. But

0:28:23.880 --> 0:28:27.800
<v Speaker 1>there's only four thousand ever approved drugs. Lily alone has

0:28:27.840 --> 0:28:31.800
<v Speaker 1>more than three million failed drugs. He's convinced that if

0:28:31.800 --> 0:28:35.399
<v Speaker 1>computers will one day design novel medications, Lily has an

0:28:35.480 --> 0:28:40.280
<v Speaker 1>unassailable headstart Rix isn't waiting for a technological revolution to

0:28:40.360 --> 0:28:43.840
<v Speaker 1>rescue the company from its impending patent cliff, though, or

0:28:43.880 --> 0:28:46.800
<v Speaker 1>from a future in which the obesity market may be saturated.

0:28:47.280 --> 0:28:50.960
<v Speaker 1>As the company looks beyond obesity, he's furiously reinvesting in

0:28:51.000 --> 0:28:54.200
<v Speaker 1>its internal pipeline and deploying its balance sheet to fund

0:28:54.200 --> 0:28:58.400
<v Speaker 1>acquisitions a record twenty billion dollars so far this year alone.

0:28:58.840 --> 0:29:02.720
<v Speaker 1>Those transactions have brought Lily into new fields and reinvigorated

0:29:02.720 --> 0:29:06.200
<v Speaker 1>old efforts in areas such as sleep disorders and infectious disease.

0:29:06.840 --> 0:29:09.880
<v Speaker 1>The company recently spent seven point eight billion dollars to

0:29:09.920 --> 0:29:14.280
<v Speaker 1>buy Sintessa Pharmaceuticals, one of its largest acquisitions ever, gaining

0:29:14.320 --> 0:29:18.360
<v Speaker 1>experimental medicines for narcolepsy and similar sleep and alertness disorders.

0:29:18.840 --> 0:29:22.160
<v Speaker 1>Lily sees sleep as an untapped opportunity with the potential

0:29:22.240 --> 0:29:24.920
<v Speaker 1>to be as big as obesity. I have a sense

0:29:24.960 --> 0:29:27.560
<v Speaker 1>it could be that the diseases of sleep, like narcolepsy,

0:29:27.600 --> 0:29:30.360
<v Speaker 1>are just the tip of the iceberg, says Skavronsky, the

0:29:30.440 --> 0:29:31.680
<v Speaker 1>chief scientific officer.

0:29:32.120 --> 0:29:33.520
<v Speaker 2>As we learn more about.

0:29:33.280 --> 0:29:35.920
<v Speaker 1>The science, maybe someday we can make medicines that can

0:29:35.960 --> 0:29:38.640
<v Speaker 1>help a broad range of people sleep better and be

0:29:38.640 --> 0:29:42.640
<v Speaker 1>better awake during the daytime. Internally, the company spent more

0:29:42.680 --> 0:29:46.120
<v Speaker 1>than thirteen billion dollars on research and development last year.

0:29:46.640 --> 0:29:50.640
<v Speaker 1>It's continuing to invest in obesity and other metabolic health conditions,

0:29:50.920 --> 0:29:56.120
<v Speaker 1>while also pouring resources into areas including cancer, immunology, neuroscience,

0:29:56.160 --> 0:29:58.920
<v Speaker 1>and gene therapy, which now accounts for a third of

0:29:58.920 --> 0:30:02.640
<v Speaker 1>its early stage pipeline. Lily recently released data from a

0:30:02.680 --> 0:30:05.800
<v Speaker 1>small initial study of a gene therapy that showed promise

0:30:05.840 --> 0:30:09.760
<v Speaker 1>in treating high cholesterol with a single infusion. Those results

0:30:09.800 --> 0:30:13.960
<v Speaker 1>garnered much fanfare, including from Elon Musk, who's used Mountjarro

0:30:14.080 --> 0:30:17.640
<v Speaker 1>to lose weight. Impressive new drugs coming from Lily, he

0:30:17.680 --> 0:30:21.240
<v Speaker 1>wrote on X. The company is weighing too, whether to

0:30:21.320 --> 0:30:25.040
<v Speaker 1>expand into consumer facing areas such as esthetics, which could

0:30:25.080 --> 0:30:28.640
<v Speaker 1>mean hair loss or skin care, and even psychedelics. According

0:30:28.640 --> 0:30:31.560
<v Speaker 1>to people familiar with its plans, it's all part of

0:30:31.600 --> 0:30:34.680
<v Speaker 1>Lily's effort to prepare for the inevitable day its GLP

0:30:34.840 --> 0:30:38.120
<v Speaker 1>one dominance ends. We spent a lot of time as

0:30:38.120 --> 0:30:41.280
<v Speaker 1>an executive committee looking at other examples of pharma companies

0:30:41.280 --> 0:30:45.160
<v Speaker 1>that have had extremely large franchises where eventually either growth

0:30:45.200 --> 0:30:49.120
<v Speaker 1>slows or they get genericized. Says Jacob Van Narden, head

0:30:49.120 --> 0:30:52.400
<v Speaker 1>of Business Development and Oncology, we are trying to do

0:30:52.480 --> 0:30:56.760
<v Speaker 1>something unbelievably hard that no one's ever done before. For Rix,

0:30:57.080 --> 0:30:59.600
<v Speaker 1>that's the largest and last item on his CEO to

0:30:59.640 --> 0:31:02.200
<v Speaker 1>do lite, which he started in a letter he wrote

0:31:02.240 --> 0:31:04.840
<v Speaker 1>to himself on a legal pad a decade ago while

0:31:04.880 --> 0:31:07.880
<v Speaker 1>taking a class for new CEOs at Harvard Business School.

0:31:08.440 --> 0:31:10.720
<v Speaker 1>If I look back at that list, most of those

0:31:10.760 --> 0:31:14.480
<v Speaker 1>things are solved, he says. Planning for continued growth after

0:31:14.600 --> 0:31:18.480
<v Speaker 1>zepbound is to me, the defining challenge we have. He adds,

0:31:18.840 --> 0:31:21.040
<v Speaker 1>there is still lots to do to check that one

0:31:21.080 --> 0:31:21.720
<v Speaker 1>off the list.